Statistical analysis methods for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
-
Multivariate Cox regression models and Kaplan–Meier survival curves were used to compare survival among treatment groups while controlling for demographics, preexisting medical conditions, and clinical disease severity
-
Bivariate comparisons of the 4 groups were made using analysis of variance or Kruskal–Wallis tests for continuous variables and chi-square tests or Fisher exact tests for categorical variables
-
A propensity score was created for each patient based on the set of patient characteristics used in the Cox regression model
-
1 to 1 matches of patients given hydroxychloroquine (either hydroxychloroquine alone or in combination with azithromycin) and patients not given hydroxychloroquine based on the exact propensity score were observed; the resulting matched group status was placed into its own Cox regression model as a mortality predictor with a Kaplan–Meier plot summarizing the survival curves of the two matched groups
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Methods for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Statistical analysis methods for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Results of Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Discussion for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19